Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Lithium hydroxide
Drug ID BADD_D01305
Description Used for tryptophan determinations in proteins & foods.
Indications and Usage Not Available
Marketing Status approved; withdrawn
ATC Code Not Available
DrugBank ID DB14506
KEGG ID D04750
MeSH ID C028467
PubChem ID 3939
TTD Drug ID Not Available
NDC Product Code Not Available
UNII G51XLP968G
Synonyms lithium hydroxide | lithium hydroxide, 7Li-labeled | lithium hydroxide monohydrate | lithium hydroxide, 6Li-labeled
Chemical Information
Molecular Formula HLiO
CAS Registry Number 1310-65-2
SMILES [Li+].[OH-]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Tremor17.01.06.002--
Urinary incontinence20.02.02.010; 17.05.01.008--
Vertigo04.04.01.003; 17.02.12.002--
Vision blurred17.17.01.010; 06.02.06.007--
Visual field defect17.17.01.001; 06.02.07.003--Not Available
Vomiting07.01.07.003--
Weight decreased13.15.01.005--
Weight increased13.15.01.006--
Musculoskeletal discomfort15.03.04.001--Not Available
Urine output increased13.13.03.002--Not Available
Mental disorder due to a general medical condition19.07.03.005--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Erectile dysfunction21.03.01.007; 19.08.04.001--
Toxicity to various agents12.03.01.046--Not Available
Sinus node dysfunction02.03.03.017--
Idiopathic intracranial hypertension17.07.02.011--Not Available
The 4th Page    First    Pre   4    Total 4 Pages